Pediatric patients requiring extracorporeal membrane oxygenation in heart failure: 30‐day outcomes; mid‐ and long‐term survival. A single center experience
Autor: | Mohamed Zeriouh, Carolyn Weber, Julia Merkle, Viktoria Weixler, Gerardus Bennink, Thorsten Wahlers, Farid Azizov, Kaveh Eghbalzadeh, Ilija Djordjevic, Axel Kröner, Anton Sabashnikov |
---|---|
Rok vydání: | 2019 |
Předmět: |
Male
medicine.medical_specialty Myocardial Failure medicine.medical_treatment 0206 medical engineering Biomedical Engineering Medicine (miscellaneous) Bioengineering Kaplan-Meier Estimate 02 engineering and technology 030204 cardiovascular system & hematology Single Center Biomaterials 03 medical and health sciences Heart disorder Extracorporeal Membrane Oxygenation 0302 clinical medicine medicine Extracorporeal membrane oxygenation Humans Child Heart Failure Univariate analysis business.industry Incidence (epidemiology) Infant General Medicine medicine.disease 020601 biomedical engineering Cardiac surgery Treatment Outcome Child Preschool Heart failure Anesthesia Female business Follow-Up Studies |
Zdroj: | Artificial Organs. 43:966-975 |
ISSN: | 1525-1594 0160-564X |
DOI: | 10.1111/aor.13501 |
Popis: | Nowadays, an increasing number of neonatal and pediatric patients with severe heart failure benefits from extracorporeal membrane oxygenation (ECMO) support. A total of 39 pediatric patients needed venoarterial ECMO (vaECMO) support in our department between January 2008 and December 2016. Patients were retrospectively divided in two groups: 30-day survivor group (17 patients) and 30-day nonsurvivor group (22 patients). Outcome and factors predictive for 30-day mortality and mid- as well as long-term survival up to 7-year follow-up were analyzed by univariate analysis and Kaplan-Meier survival estimation. Basic demographics and preoperative characteristics did not differ between groups (P > 0.05). 67% of patients were successfully weaned off ECMO and 44% survived 30-day after ECMO application. After 7-year follow-up 28% of pediatric patients were alive. Thirty-day survivors were significantly more likely to undergo elective cardiac surgery (P = 0.001), whereas significantly more 30-day nonsurvivors underwent urgent surgery (P = 0.004). Odds of incidence of catecholamine refractory circulatory failure, failed myocardial recovery, and cerebral edema was significantly higher in 30-day nonsurvivor group (41.6-fold, 16-fold, and 2.5-fold, respectively). Kaplan-Meier survival estimation analysis revealed significant differences in terms of mid- and long-term survival among neonates, infants, toddlers, and preadolescents (Breslow P = 0.037 and Log-Rank P = 0.028, respectively). vaECMO provides an efficient therapy option for life-threatening heart disorders in neonates and pediatric patients being at high risk for myocardial failure leading to circulatory arrest. Urgency of surgery effected on higher mortality, but there was no difference in terms of mortality in 30-day survivor group in comparison to 30-day nonsurvivor group among neonates, infants, toddlers, and preadolescents. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |